Literature DB >> 7766338

Drug-induced mania.

M Peet1, S Peters.   

Abstract

Mania can occur by chance association during drug treatment, particularly in patients predisposed to mood disorder. Single case reports are unreliable, and evidence must be sought from large series of treated patients, particularly those with a matched control group. Drugs with a definite propensity to cause manic symptoms include levodopa, corticosteroids and anabolic-androgenic steroids. Antidepressants of the tricyclic and monoamine oxidase inhibitor classes can induce mania in patients with pre-existing bipolar affective disorder. Drugs which are probably capable of inducing mania, but for which the evidence is less scientifically secure, include other dopaminergic anti-Parkinsonian drugs, thyroxine, iproniazid and isoniazid, sympathomimetic drugs, chloroquine, baclofen, alprazolam, captopril, amphetamine and phencyclidine. Other drugs may induce mania rarely and idiosyncratically. Management involves discontinuation or dosage reduction of the suspected drug, if this is medically possible, and treatment of manic symptoms with antipsychotic drugs or lithium.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7766338     DOI: 10.2165/00002018-199512020-00007

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  85 in total

1.  A cross-national epidemiological study of mania.

Authors:  J P Leff; M Fischer; A Bertelsen
Journal:  Br J Psychiatry       Date:  1976-11       Impact factor: 9.319

2.  Lithium prophylaxis of corticotropin-induced psychosis.

Authors:  W E Falk; M W Mahnke; D C Poskanzer
Journal:  JAMA       Date:  1979-03-09       Impact factor: 56.272

3.  Regular induction of hypomania by L-dopa in "bipolar" manic-depressive patients.

Authors:  D L Murphy; H K Brodie; F K Goodwin; W E Bunney
Journal:  Nature       Date:  1971-01-08       Impact factor: 49.962

4.  Manic response to levodopa therapy. Report of a case.

Authors:  R S Ryback; R S Schwab
Journal:  N Engl J Med       Date:  1971-09-30       Impact factor: 91.245

5.  Paradoxical mood shifts to euthymia or hypomania upon withdrawal of antidepressant agents.

Authors:  P J McGrath; J W Stewart; E Tricamo; E N Nunes; F M Quitkin
Journal:  J Clin Psychopharmacol       Date:  1993-06       Impact factor: 3.153

6.  Bromocriptine-induced mania?

Authors:  N M Brook; I B Cookson
Journal:  Br Med J       Date:  1978-03-25

Review 7.  Can antidepressants cause mania and worsen the course of affective illness?

Authors:  T A Wehr; F K Goodwin
Journal:  Am J Psychiatry       Date:  1987-11       Impact factor: 18.112

Review 8.  Baclofen-induced psychosis: two cases and a review.

Authors:  R Y Yassa; H L Iskandar
Journal:  J Clin Psychiatry       Date:  1988-08       Impact factor: 4.384

Review 9.  Risk of recurrence following discontinuation of lithium treatment in bipolar disorder.

Authors:  T Suppes; R J Baldessarini; G L Faedda; M Tohen
Journal:  Arch Gen Psychiatry       Date:  1991-12

10.  Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature.

Authors:  D A Lewis; R E Smith
Journal:  J Affect Disord       Date:  1983-11       Impact factor: 4.839

View more
  29 in total

1.  Identification and treatment of a pineal region tumor in an adolescent with prodromal psychotic symptoms.

Authors:  Vijay A Mittal; Katherine Karlsgodt; Jamie Zinberg; Tyrone D Cannon; Carrie E Bearden
Journal:  Am J Psychiatry       Date:  2010-09       Impact factor: 18.112

2.  Chronic valproate treatment blocks D2-like receptor-mediated brain signaling via arachidonic acid in rats.

Authors:  Epolia Ramadan; Mireille Basselin; Ameer Y Taha; Yewon Cheon; Lisa Chang; Mei Chen; Stanley I Rapoport
Journal:  Neuropharmacology       Date:  2011-08-03       Impact factor: 5.250

Review 3.  Animal models of bipolar mania: The past, present and future.

Authors:  R W Logan; C A McClung
Journal:  Neuroscience       Date:  2015-08-24       Impact factor: 3.590

4.  Fenproporex increases locomotor activity and alters energy metabolism, and mood stabilizers reverse these changes: a proposal for a new animal model of mania.

Authors:  Gislaine T Rezin; Camila B Furlanetto; Giselli Scaini; Samira S Valvassori; Cinara L Gonçalves; Gabriela K Ferreira; Isabela C Jeremias; Wilson R Resende; Mariane R Cardoso; Roger B Varela; João Quevedo; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2013-10-15       Impact factor: 5.590

5.  50 Useful Sociodemographic and Clinical Tips to Overcome the Challenge Differentiating Bipolar Depression from Unipolar Depression.

Authors:  Halil Ozcan; Ugur Takim
Journal:  Eurasian J Med       Date:  2021-02

6.  A case of chloroquine-induced recurrent mania.

Authors:  Manjeet S Bhatia; Anurag Jhanjee; Anant Oberoi
Journal:  Prim Care Companion CNS Disord       Date:  2012-05-17

Review 7.  The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited.

Authors:  Jordy van Enkhuizen; David S Janowsky; Berend Olivier; Arpi Minassian; William Perry; Jared W Young; Mark A Geyer
Journal:  Eur J Pharmacol       Date:  2014-08-05       Impact factor: 4.432

Review 8.  Tamoxifen use for the management of mania: a review of current preclinical evidence.

Authors:  Fernanda Armani; Monica Levy Andersen; José Carlos Fernandes Galduróz
Journal:  Psychopharmacology (Berl)       Date:  2014-01-18       Impact factor: 4.530

Review 9.  Frontotemporal and dopaminergic control of idea generation and creative drive.

Authors:  Alice W Flaherty
Journal:  J Comp Neurol       Date:  2005-12-05       Impact factor: 3.215

10.  Mapping mania symptoms based on focal brain damage.

Authors:  Gonçalo Cotovio; Daniel Talmasov; J Bernardo Barahona-Corrêa; Joey Hsu; Suhan Senova; Ricardo Ribeiro; Louis Soussand; Ana Velosa; Vera Cruz E Silva; Natalia Rost; Ona Wu; Alexander L Cohen; Albino J Oliveira-Maia; Michael D Fox
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.